(Q40591119)

21 September 2017

title

Soluble Fas: a novel predictor of atherosclerosis in dialysis patients (English)

1 reference

21 September 2017

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00202-6

29 December 2023

2

Marie-Josée Hébert

1 reference

21 September 2017

Stéphan Troyanov

1

1 reference

21 September 2017

Mélanie Masse

3

1 reference

21 September 2017

Normand Vigneault

4

1 reference

21 September 2017

Isabelle Sirois

5

1 reference

21 September 2017

François Madore

6

1 reference

21 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12722039

29 December 2023

publication date

1 May 2003

1 reference

full work available at URL

21 September 2017

https://api.elsevier.com/content/article/PII:S0272638603002026?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00202-6

https://api.elsevier.com/content/article/PII:S0272638603002026?httpAccept=text/plain

29 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00202-6

American Journal of Kidney Diseases

29 December 2023

published in

1 reference

21 September 2017

volume

41

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

1043-1051

1 reference

Changing concepts of atherogenesis

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

The oxidative modification hypothesis of atherogenesis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

1 reference

7 January 2021

Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Soluble Fas Apo-1 splicing variants and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Fas-Fas ligand system in the peripheral blood of patients with renal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Cardiovascular disease in end-stage renal disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Cardiac and cerebrovascular disease in chronic uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Apoptosis by death factor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Progression of atheroma: a struggle between death and procreation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Novel clinical markers of vascular wall inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Increased plasma levels of the soluble form of Fas ligand in patients with acute myocardial infarction and unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Soluble antiapoptotic molecules and immune activation in chronic heart failure and unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Fas ligand overexpression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Estrogen receptor-mediated, nitric oxide-dependent modulation of the immunologic barrier function of the endothelium: regulation of fas ligand expression by estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Sudden death due to cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Soluble Fas ligand and atherosclerosis in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900202-6

7 January 2021

Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing

31

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00202-6

A form of circulating ICAM-1 in human serum

29 December 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00202-6

Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions

29 December 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00202-6

29 December 2023

Identifiers

1 reference

21 September 2017

1 reference